IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Johnson & Johnson Innovation - Jjdc, Inc.

Q1 2020 Holdings

Filed 2020-05-13 | 12 holdings | $95.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals(ARWR)COM04280A100$93.8M3,260,86998.4%
Aldeyra Therapeutics, Inc.(ALDX)COM01438T106$1.5M594,8341.5%
MeiraGTx Holdings plc(MGTX)COMG59665102$39.0K2,898,5500.0%
Protagonist Therapeutics Inc.(PTGX)COM74366E102$17.3K2,449,1830.0%
BiomX Inc.COM09090D103$14.9K2,133,4020.0%
Provention Bio, Inc.(PRVBUSD)COM74374N102$10.4K1,124,9730.0%
PhaseBio Pharmaceuticals, Inc.COM717224109$5.3K1,607,0440.0%
Castlight Health Inc.(CSLT1EUR)CL B14862Q100$587811,2950.0%
Senseonics Holdings, Inc.(SENS1GBP)COM81727U105$333525,6320.0%
Catalyst Biosciences, Inc.COM14888D208$29366,9510.0%
Genocea Biosciences, Inc.(GNCAQ)COM372427401$248143,9640.0%
Tracon Pharmaceuticals, Inc.COM89237H209$14384,0030.0%